Harrow Inc (HROW)
43.93
+1.49
(+3.51%)
USD |
NASDAQ |
Nov 21, 16:00
43.58
-0.35
(-0.80%)
After-Hours: 18:22
Harrow Price to Book Value: 26.99 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 20, 2024 | 26.07 |
November 19, 2024 | 24.39 |
November 18, 2024 | 23.32 |
November 15, 2024 | 23.96 |
November 14, 2024 | 26.33 |
November 13, 2024 | 31.82 |
November 12, 2024 | 30.66 |
November 11, 2024 | 31.95 |
November 08, 2024 | 32.25 |
November 07, 2024 | 30.66 |
November 06, 2024 | 29.63 |
November 05, 2024 | 28.13 |
November 04, 2024 | 28.15 |
November 01, 2024 | 28.03 |
October 31, 2024 | 27.68 |
October 30, 2024 | 27.28 |
October 29, 2024 | 28.59 |
October 28, 2024 | 28.99 |
October 25, 2024 | 31.08 |
October 24, 2024 | 32.58 |
October 23, 2024 | 33.30 |
October 22, 2024 | 35.00 |
October 21, 2024 | 34.66 |
October 18, 2024 | 35.31 |
October 17, 2024 | 34.65 |
Date | Value |
---|---|
October 16, 2024 | 33.67 |
October 15, 2024 | 32.86 |
October 14, 2024 | 31.26 |
October 11, 2024 | 31.15 |
October 10, 2024 | 30.51 |
October 09, 2024 | 31.32 |
October 08, 2024 | 31.33 |
October 07, 2024 | 31.11 |
October 04, 2024 | 30.94 |
October 03, 2024 | 30.56 |
October 02, 2024 | 28.18 |
October 01, 2024 | 27.30 |
September 30, 2024 | 27.62 |
September 27, 2024 | 26.72 |
September 26, 2024 | 26.81 |
September 25, 2024 | 26.95 |
September 24, 2024 | 27.83 |
September 23, 2024 | 26.94 |
September 20, 2024 | 27.29 |
September 19, 2024 | 28.17 |
September 18, 2024 | 27.48 |
September 17, 2024 | 26.41 |
September 16, 2024 | 26.66 |
September 13, 2024 | 27.36 |
September 12, 2024 | 25.50 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.224
Minimum
Mar 23 2020
361.79
Maximum
Dec 29 2022
27.92
Average
11.25
Median
Aug 23 2021
Price to Book Value Benchmarks
Calidi Biotherapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | 3.291 |
Palatin Technologies Inc | -- |
iBio Inc | 1.263 |
Theriva Biologics Inc | 0.1446 |
Price to Book Value Related Metrics
PS Ratio | 9.233 |
PEG Ratio | -0.4162 |
Price to Free Cash Flow | 528.27 |
Price | 43.93 |
Earnings Yield | -2.16% |
Market Cap | 1.565B |
PEGY Ratio | -0.4162 |